Paroxetine and Suicidal ideation - a phase IV clinical study of FDA data

Summary:

Suicidal ideation is found among people who take Paroxetine, especially for people who are female, 30-39 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Paroxetine and have Suicidal ideation. It is created by eHealthMe based on reports of 56,969 people who have side effects when taking Paroxetine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 29, 2023

56,969 people reported to have side effects when taking Paroxetine.
Among them, 2,774 people (4.87%) have Suicidal ideation.

What is Paroxetine?

Paroxetine has active ingredients of paroxetine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 58,214 Paroxetine users for its effectiveness, alternative drugs and more.

What is Suicidal ideation?

Suicidal ideation is found to be associated with 2,991 drugs and 2,309 conditions by eHealthMe.

Number of Paroxetine and Suicidal ideation reports submitted per year:

Could Paroxetine cause Suicidal ideation?

* Approximation only. Some reports may have incomplete information.

Do you take Paroxetine and have Suicidal ideation?

Check whether Suicidal ideation is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Coskun M, Adak I, Akaltun I, "Bilateral gynecomastia in a preadolescent boy while under treatment with methylphenidate and paroxetine", Journal of clinical psychopharmacology, 2014 Aug .

Related studies

How severe was Suicidal ideation and when was it recovered:

Suicidal ideation in Paroxetine

Expand to all the drugs that have ingredients of paroxetine hydrochloride:

Suicidal ideation and drugs with ingredients of paroxetine hydrochloride (6,387 reports)

Alternative drugs to, pros and cons of Paroxetine:

Paroxetine (58,214 reports)

Common Paroxetine side effects:

Stress and anxiety: 4,007 reports
Fatigue (feeling of tiredness): 3,970 reports
Dizziness: 3,506 reports
Drug ineffective: 3,397 reports
Depression: 3,150 reports
Headache (pain in head): 3,042 reports
Diarrhea: 3,038 reports

Browse all side effects of Paroxetine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Suicidal ideation treatments and more:

Suicidal ideation (98,533 reports)

COVID vaccines that are related to Suicidal ideation:

Common drugs associated with Suicidal ideation:

All the drugs that are associated with Suicidal ideation:

Suicidal ideation (2,991 drugs)

Common conditions associated with Suicidal ideation:

Depression: 14,316 reports
Stress and anxiety: 5,752 reports
Pain: 5,213 reports
Quit smoking: 4,077 reports
Bipolar disorder: 3,290 reports

All the conditions that are associated with Suicidal ideation:

Suicidal ideation (2,309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paroxetine hydrochloride (the active ingredients of Paroxetine) and Paroxetine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.